Our technology reveals the UTR landscape of expressed transcripts at single nucleotide resolution through mapping 5’ ends and 3’ ends.
Regulatory elements in 5′ and 3′ UTRs have been implicated in human disease and can function as therapeutic targets.
To learn more, click here.
The Eclipsebio team is committed to supporting academia and industry in revolutionizing the emerging field of
RNA next generation sequencing (NGS). Our first-in-class eCLIP products and services strengthen and refine RNA NGS methods that help our customers make new scientific discoveries and accelerate the development of RNA therapeutics.
